ID   EXT2_HUMAN              Reviewed;         718 AA.
AC   Q93063; B2R5Z6; C9JU51; J3KPT2; O15288;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   10-MAY-2017, entry version 172.
DE   RecName: Full=Exostosin-2;
DE            EC=2.4.1.224;
DE            EC=2.4.1.225;
DE   AltName: Full=Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;
DE   AltName: Full=Multiple exostoses protein 2;
DE   AltName: Full=Putative tumor suppressor protein EXT2;
GN   Name=EXT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8782816; DOI=10.1038/ng0996-25;
RA   Stickens D.J., Clines G., Burbee D.G., Ramos P., Thomas S., Hogue D.,
RA   Hecht J.T., Lovett M., Evans G.A.;
RT   "The EXT2 multiple exostoses gene defines a family of putative tumour
RT   suppressor genes.";
RL   Nat. Genet. 14:25-32(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8894688; DOI=10.1093/hmg/5.10.1547;
RA   Wuyts W., van Hul W., Wauters J., Nemtsova M., Reyniers E.,
RA   van Hul E., de Boulle K., de Vries B.B.A., Hendrickx J., Herrygers I.,
RA   Bossuyt P., Balemans W., Fransen E., Vits L., Coucke P., Nowak N.J.,
RA   Mallet L., van den Ouweland A.M.W., McGaughran J., Halley D.J.J.,
RA   Willems P.J.;
RT   "Positional cloning of a gene involved in hereditary multiple
RT   exostoses.";
RL   Hum. Mol. Genet. 5:1547-1557(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=9110175;
RA   Clines G.A., Ashley J.A., Shah S., Lovett M.;
RT   "The structure of the human multiple exostoses 2 gene and
RT   characterization of homologs in mouse and Caenorhabditis elegans.";
RL   Genome Res. 7:359-367(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RA   Deng H.-X., Fan C., Xia J.H., Xu L., He X.X., Ruan Q.G., Yang Y.,
RA   Huang L.;
RT   "Molecular cloning of a candidate gene for hereditary multiple
RT   exostoses type II.";
RL   Prog. Nat. Sci. 6:692-699(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Endometrial cancer;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=10679296; DOI=10.1006/bbrc.2000.2219;
RA   Kobayashi S., Morimoto K., Shimizu T., Takahashi M., Kurosawa H.,
RA   Shirasawa T.;
RT   "Association of EXT1 and EXT2, hereditary multiple exostoses gene
RT   products, in Golgi apparatus.";
RL   Biochem. Biophys. Res. Commun. 268:860-867(2000).
RN   [11]
RP   INTERACTION WITH GALNT5.
RX   PubMed=10545594; DOI=10.1093/hmg/8.12.2155;
RA   Simmons A.D., Musy M.M., Lopes C.S., Hwang L.-Y., Yang Y.-P.,
RA   Lovett M.;
RT   "A direct interaction between EXT proteins and glycosyltransferases is
RT   defective in hereditary multiple exostoses.";
RL   Hum. Mol. Genet. 8:2155-2164(1999).
RN   [12]
RP   REVIEW ON VARIANTS.
RX   PubMed=10679937;
RX   DOI=10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K;
RA   Wuyts W., Van Hul W.;
RT   "Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2
RT   genes.";
RL   Hum. Mutat. 15:220-227(2000).
RN   [13]
RP   INTERACTION WITH NDST1.
RX   PubMed=18337501; DOI=10.1073/pnas.0705807105;
RA   Presto J., Thuveson M., Carlsson P., Busse M., Wilen M., Eriksson I.,
RA   Kusche-Gullberg M., Kjellen L.;
RT   "Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1
RT   expression and heparan sulfate sulfation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:4751-4756(2008).
RN   [14]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G.,
RA   Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E.,
RA   Zimmermann P., David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [15]
RP   INVOLVEMENT IN SSMS, VARIANTS SSMS ARG-87 AND CYS-95, AND
RP   CHARACTERIZATION OF VARIANTS SSMS ARG-87 AND CYS-95.
RX   PubMed=26246518; DOI=10.1136/jmedgenet-2015-103279;
RG   FORGE Canada Consortium;
RA   Farhan S.M., Wang J., Robinson J.F., Prasad A.N., Rupar C.A.,
RA   Siu V.M., Hegele R.A.;
RT   "Old gene, new phenotype: mutations in heparan sulfate synthesis
RT   enzyme, EXT2 leads to seizure and developmental disorder, no
RT   exostoses.";
RL   J. Med. Genet. 52:666-675(2015).
RN   [16]
RP   VARIANT EXT2 ASN-227.
RX   PubMed=9326317; DOI=10.1086/515505;
RA   Philippe C., Porter D.E., Emerton M.E., Wells D.E., Simpson A.H.R.W.,
RA   Monaco A.P.;
RT   "Mutation screening of the EXT1 and EXT2 genes in patients with
RT   hereditary multiple exostoses.";
RL   Am. J. Hum. Genet. 61:520-528(1997).
RN   [17]
RP   VARIANT EXT2 ARG-152, AND ALTERNATIVE SPLICING.
RX   PubMed=10480354; DOI=10.1007/s004399900058;
RA   Xu L., Xia J., Jiang H., Zhou J., Li H., Wang D., Pan Q., Long Z.,
RA   Fan C., Deng H.-X.;
RT   "Mutation analysis of hereditary multiple exostoses in the Chinese.";
RL   Hum. Genet. 105:45-50(1999).
RN   [18]
RP   VARIANT EXT2 ARG-85.
RX   PubMed=10429361; DOI=10.1007/s100380050149;
RA   Park K.J., Shin K.-H., Ku J.-L., Cho T.-J., Lee S.H., Choi I.H.,
RA   Philippe C., Monaco A.P., Porter D.E., Park J.-G.;
RT   "Germline mutations in the EXT1 and EXT2 genes in Korean patients with
RT   hereditary multiple exostoses.";
RL   J. Hum. Genet. 44:230-234(1999).
RN   [19]
RP   VARIANT EXT2 PRO-223.
RX   PubMed=10738008;
RX   DOI=10.1002/(SICI)1098-1004(200004)15:4<390::AID-HUMU35>3.0.CO;2-E;
RA   Shi Y.-R., Wu J.-Y., Tsai F.-J., Lee C.-C., Tsai C.-H.;
RT   "An R223P mutation in EXT2 gene causes hereditary multiple
RT   exostoses.";
RL   Hum. Mutat. 15:390-391(2000).
RN   [20]
RP   VARIANT EXT2 VAL-202.
RX   PubMed=11170095;
RX   DOI=10.1002/1096-8628(20010215)99:1<59::AID-AJMG1115>3.0.CO;2-Z;
RA   Seki H., Kubota T., Ikegawa S., Haga N., Fujioka F., Ohzeki S.,
RA   Wakui K., Yoshikawa H., Takaoka K., Fukushima Y.;
RT   "Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with
RT   hereditary multiple exostoses.";
RL   Am. J. Med. Genet. 99:59-62(2001).
RN   [21]
RP   VARIANT EXT2 ASN-227.
RX   PubMed=11169766;
RX   DOI=10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3;
RA   Bernard M.A., Hall C.E., Hogue D.A., Cole W.G., Scott A., Snuggs M.B.,
RA   Clines G.A., Luedecke H.-J., Lovett M., Van Winkle W.B., Hecht J.T.;
RT   "Diminished levels of the putative tumor suppressor proteins EXT1 and
RT   EXT2 in exostosis chondrocytes.";
RL   Cell Motil. Cytoskeleton 48:149-162(2001).
RN   [22]
RP   VARIANT EXT2 THR-380, AND VARIANT OSTEOCHONDROMA LYS-576.
RX   PubMed=11668521;
RX   DOI=10.1002/1097-0215(20011120)95:6<378::AID-IJC1067>3.0.CO;2-F;
RA   Gigante M., Matera M.G., Seripa D., Izzo A.M., Venanzi R.,
RA   Giannotti A., Digilio M.C., Gravina C., Lazzari M., Monteleone G.,
RA   Monteleone M., Dallapiccola B., Fazio V.M.;
RT   "Ext-mutation analysis in Italian sporadic and hereditary
RT   osteochondromas.";
RL   Int. J. Cancer 95:378-383(2001).
RN   [23]
RP   VARIANTS EXT2 SER-179 AND ASN-227.
RX   PubMed=11432960; DOI=10.1136/jmg.38.7.430;
RA   Francannet C., Cohen-Tanugi A., Le Merrer M., Munnich A.,
RA   Bonaventure J., Legeai-Mallet L.;
RT   "Genotype-phenotype correlation in hereditary multiple exostoses.";
RL   J. Med. Genet. 38:430-434(2001).
RN   [24]
RP   VARIANT EXT2 ASN-227.
RX   PubMed=19344451; DOI=10.1111/j.1469-1809.2009.00508.x;
RA   Heinritz W., Hueffmeier U., Strenge S., Miterski B., Zweier C.,
RA   Leinung S., Bohring A., Mitulla B., Peters U., Froster U.G.;
RT   "New mutations of EXT1 and EXT2 genes in German patients with Multiple
RT   Osteochondromas.";
RL   Ann. Hum. Genet. 73:283-291(2009).
CC   -!- FUNCTION: Glycosyltransferase required for the biosynthesis of
CC       heparan-sulfate. The EXT1/EXT2 complex possesses substantially
CC       higher glycosyltransferase activity than EXT1 or EXT2 alone.
CC       Appears to be a tumor suppressor. Required for the exosomal
CC       release of SDCBP, CD63 and syndecan (PubMed:22660413).
CC       {ECO:0000269|PubMed:22660413}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-glucosamine + beta-D-
CC       glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan =
CC       UDP + N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-
CC       (1->4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + N-acetyl-alpha-D-
CC       glucosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan = UDP + beta-
CC       D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-
CC       glucuronosyl-proteoglycan.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9ES89};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Forms a homo/hetero-oligomeric complex with EXT1.
CC       Interacts with GALNT5. Interacts with NDST1.
CC       {ECO:0000269|PubMed:10545594, ECO:0000269|PubMed:10679296,
CC       ECO:0000269|PubMed:18337501}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10679296}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:10679296}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10679296}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:10679296}. Note=The EXT1/EXT2 complex
CC       is localized in the Golgi apparatus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q93063-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q93063-2; Sequence=VSP_001798;
CC         Note=Ref.4 (AAB62718) sequence is in conflict in position:
CC         397:A->V. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q93063-3; Sequence=VSP_046053;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Hereditary multiple exostoses 2 (EXT2) [MIM:133701]: EXT
CC       is a genetically heterogeneous bone disorder caused by genes
CC       segregating on human chromosomes 8, 11, and 19 and designated
CC       EXT1, EXT2 and EXT3 respectively. EXT is a dominantly inherited
CC       skeletal disorder primarily affecting endochondral bone during
CC       growth. The disease is characterized by formation of numerous
CC       cartilage-capped, benign bone tumors (osteocartilaginous exostoses
CC       or osteochondromas) that are often accompanied by skeletal
CC       deformities and short stature. In a small percentage of cases
CC       exostoses have exhibited malignant transformation resulting in an
CC       osteosarcoma or chondrosarcoma. Osteochondromas development can
CC       also occur as a sporadic event. {ECO:0000269|PubMed:10429361,
CC       ECO:0000269|PubMed:10480354, ECO:0000269|PubMed:10738008,
CC       ECO:0000269|PubMed:11169766, ECO:0000269|PubMed:11170095,
CC       ECO:0000269|PubMed:11432960, ECO:0000269|PubMed:11668521,
CC       ECO:0000269|PubMed:19344451, ECO:0000269|PubMed:9326317}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Potocki-Shaffer syndrome (POSHS) [MIM:601224]: A syndrome
CC       characterized by foramina parietalia permagna, multiple exostoses,
CC       and craniofacial dysostosis and mental retardation in some cases.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis.
CC   -!- DISEASE: Seizures, scoliosis, and macrocephaly syndrome (SSMS)
CC       [MIM:616682]: An autosomal recessive syndrome characterized by
CC       seizures, intellectual disability, hypotonia, scoliosis,
CC       macrocephaly, hypertelorism and renal dysfunction.
CC       {ECO:0000269|PubMed:26246518}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 47 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EXT2ID213.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U62740; AAB07008.1; -; mRNA.
DR   EMBL; U64511; AAC50764.1; -; mRNA.
DR   EMBL; U67368; AAC51219.1; -; Genomic_DNA.
DR   EMBL; U67356; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67357; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67358; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67360; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67361; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67362; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67363; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67364; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67365; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67366; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U67367; AAC51219.1; JOINED; Genomic_DNA.
DR   EMBL; U72263; AAB62718.1; -; mRNA.
DR   EMBL; AK312375; BAG35293.1; -; mRNA.
DR   EMBL; BX648142; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC068457; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103854; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC134775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68068.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68070.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68071.1; -; Genomic_DNA.
DR   EMBL; BC010058; AAH10058.1; -; mRNA.
DR   CCDS; CCDS53618.1; -. [Q93063-3]
DR   CCDS; CCDS53619.1; -. [Q93063-2]
DR   CCDS; CCDS7908.1; -. [Q93063-1]
DR   RefSeq; NP_000392.3; NM_000401.3. [Q93063-3]
DR   RefSeq; NP_001171554.1; NM_001178083.1. [Q93063-2]
DR   RefSeq; NP_997005.1; NM_207122.1. [Q93063-1]
DR   UniGene; Hs.368404; -.
DR   ProteinModelPortal; Q93063; -.
DR   SMR; Q93063; -.
DR   BioGrid; 108433; 31.
DR   IntAct; Q93063; 9.
DR   MINT; MINT-120303; -.
DR   STRING; 9606.ENSP00000379032; -.
DR   CAZy; GT47; Glycosyltransferase Family 47.
DR   CAZy; GT64; Glycosyltransferase Family 64.
DR   iPTMnet; Q93063; -.
DR   PhosphoSitePlus; Q93063; -.
DR   BioMuta; EXT2; -.
DR   DMDM; 3023739; -.
DR   EPD; Q93063; -.
DR   MaxQB; Q93063; -.
DR   PaxDb; Q93063; -.
DR   PeptideAtlas; Q93063; -.
DR   PRIDE; Q93063; -.
DR   DNASU; 2132; -.
DR   Ensembl; ENST00000343631; ENSP00000342656; ENSG00000151348. [Q93063-1]
DR   Ensembl; ENST00000358681; ENSP00000351509; ENSG00000151348. [Q93063-2]
DR   Ensembl; ENST00000395673; ENSP00000379032; ENSG00000151348. [Q93063-3]
DR   Ensembl; ENST00000533608; ENSP00000431173; ENSG00000151348. [Q93063-1]
DR   GeneID; 2132; -.
DR   KEGG; hsa:2132; -.
DR   UCSC; uc001mxz.4; human. [Q93063-1]
DR   CTD; 2132; -.
DR   DisGeNET; 2132; -.
DR   GeneCards; EXT2; -.
DR   GeneReviews; EXT2; -.
DR   HGNC; HGNC:3513; EXT2.
DR   HPA; HPA078409; -.
DR   MalaCards; EXT2; -.
DR   MIM; 133701; phenotype.
DR   MIM; 601224; phenotype.
DR   MIM; 608210; gene.
DR   MIM; 616682; phenotype.
DR   neXtProt; NX_Q93063; -.
DR   OpenTargets; ENSG00000151348; -.
DR   Orphanet; 321; Multiple osteochondromas.
DR   Orphanet; 52022; Potocki-Shaffer syndrome.
DR   PharmGKB; PA27925; -.
DR   eggNOG; KOG1021; Eukaryota.
DR   eggNOG; ENOG410XTFH; LUCA.
DR   GeneTree; ENSGT00550000074496; -.
DR   HOGENOM; HOG000266990; -.
DR   HOVERGEN; HBG101211; -.
DR   InParanoid; Q93063; -.
DR   KO; K02367; -.
DR   OMA; QFGYEVW; -.
DR   OrthoDB; EOG091G02GW; -.
DR   PhylomeDB; Q93063; -.
DR   TreeFam; TF314231; -.
DR   BioCyc; MetaCyc:HS07726-MONOMER; -.
DR   BRENDA; 2.4.1.224; 2681.
DR   BRENDA; 2.4.1.225; 2681.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   SIGNOR; Q93063; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; EXT2; human.
DR   GeneWiki; EXT2_(gene); -.
DR   GenomeRNAi; 2132; -.
DR   PRO; PR:Q93063; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000151348; -.
DR   CleanEx; HS_EXT2; -.
DR   ExpressionAtlas; Q93063; baseline and differential.
DR   Genevisible; Q93063; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043541; C:UDP-N-acetylglucosamine transferase complex; IDA:BHF-UCL.
DR   GO; GO:0050508; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0042328; F:heparan sulfate N-acetylglucosaminyltransferase activity; NAS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050509; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; NAS:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0016757; F:transferase activity, transferring glycosyl groups; IDA:BHF-UCL.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0033692; P:cellular polysaccharide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0001707; P:mesoderm formation; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IMP:BHF-UCL.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR004263; Exostosin.
DR   InterPro; IPR027673; Exostosin-2.
DR   InterPro; IPR015338; EXT_C.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR11062:SF121; PTHR11062:SF121; 1.
DR   Pfam; PF03016; Exostosin; 1.
DR   Pfam; PF09258; Glyco_transf_64; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Disulfide bond; Endoplasmic reticulum; Epilepsy; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Hereditary multiple exostoses;
KW   Manganese; Membrane; Mental retardation; Metal-binding; Polymorphism;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix; Tumor suppressor.
FT   CHAIN         1    718       Exostosin-2.
FT                                /FTId=PRO_0000149651.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     47    718       Lumenal. {ECO:0000255}.
FT   REGION      517    522       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   REGION      538    540       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   REGION      624    628       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   REGION      662    673       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   ACT_SITE    628    628       {ECO:0000250|UniProtKB:Q9ES89}.
FT   METAL       540    540       Manganese; catalytic.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   BINDING     490    490       Substrate.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   BINDING     569    569       Substrate.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   CARBOHYD    288    288       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    637    637       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    626    676       {ECO:0000250|UniProtKB:Q9ES89}.
FT   VAR_SEQ       1      1       M -> MSCASGSGGGLRHPLRCQKPWDEECEEEAVCVIM
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_046053.
FT   VAR_SEQ     392    411       ARWFWEAYFQSIKAIALATL -> LFMEPARRENWSAANHQ
FT                                MNSLIWPREQWDS (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001798.
FT   VARIANT      42     42       M -> V (in dbSNP:rs4755779).
FT                                /FTId=VAR_033921.
FT   VARIANT      85     85       C -> R (in EXT2).
FT                                {ECO:0000269|PubMed:10429361}.
FT                                /FTId=VAR_012823.
FT   VARIANT      87     87       M -> R (in SSMS; decreased protein
FT                                abundance; levels of the EXT2-interacting
FT                                protein NDST1 are abolished in patient
FT                                cells; dbSNP:rs140075817).
FT                                {ECO:0000269|PubMed:26246518}.
FT                                /FTId=VAR_076469.
FT   VARIANT      95     95       R -> C (in SSMS; decreased protein
FT                                abundance; levels of the EXT2-interacting
FT                                protein NDST1 are abolished in patient
FT                                cells; dbSNP:rs376292686).
FT                                {ECO:0000269|PubMed:26246518}.
FT                                /FTId=VAR_076470.
FT   VARIANT     152    152       L -> R (in EXT2).
FT                                {ECO:0000269|PubMed:10480354}.
FT                                /FTId=VAR_012824.
FT   VARIANT     179    179       R -> S (in EXT2).
FT                                {ECO:0000269|PubMed:11432960}.
FT                                /FTId=VAR_012825.
FT   VARIANT     202    202       A -> V (in EXT2; dbSNP:rs771803942).
FT                                {ECO:0000269|PubMed:11170095}.
FT                                /FTId=VAR_012826.
FT   VARIANT     223    223       R -> P (in EXT2; dbSNP:rs764379119).
FT                                {ECO:0000269|PubMed:10738008}.
FT                                /FTId=VAR_012827.
FT   VARIANT     227    227       D -> N (in EXT2; no effect on oligomeric
FT                                complex formation with EXT1;
FT                                dbSNP:rs121918280).
FT                                {ECO:0000269|PubMed:11169766,
FT                                ECO:0000269|PubMed:11432960,
FT                                ECO:0000269|PubMed:19344451,
FT                                ECO:0000269|PubMed:9326317}.
FT                                /FTId=VAR_002378.
FT   VARIANT     380    380       I -> T (in EXT2).
FT                                {ECO:0000269|PubMed:11668521}.
FT                                /FTId=VAR_012828.
FT   VARIANT     576    576       E -> K (in osteochondroma;
FT                                dbSNP:rs373582542).
FT                                {ECO:0000269|PubMed:11668521}.
FT                                /FTId=VAR_012829.
FT   CONFLICT    322    322       R -> H (in Ref. 5; BX648142).
FT                                {ECO:0000305}.
FT   CONFLICT    568    568       G -> D (in Ref. 4; AAB62718).
FT                                {ECO:0000305}.
SQ   SEQUENCE   718 AA;  82255 MW;  9048CD3A5B63C5CB CRC64;
     MCASVKYNIR GPALIPRMKT KHRIYYITLF SIVLLGLIAT GMFQFWPHSI ESSNDWNVEK
     RSIRDVPVVR LPADSPIPER GDLSCRMHTC FDVYRCGFNP KNKIKVYIYA LKKYVDDFGV
     SVSNTISREY NELLMAISDS DYYTDDINRA CLFVPSIDVL NQNTLRIKET AQAMAQLSRW
     DRGTNHLLFN MLPGGPPDYN TALDVPRDRA LLAGGGFSTW TYRQGYDVSI PVYSPLSAEV
     DLPEKGPGPR QYFLLSSQVG LHPEYREDLE ALQVKHGESV LVLDKCTNLS EGVLSVRKRC
     HKHQVFDYPQ VLQEATFCVV LRGARLGQAV LSDVLQAGCV PVVIADSYIL PFSEVLDWKR
     ASVVVPEEKM SDVYSILQSI PQRQIEEMQR QARWFWEAYF QSIKAIALAT LQIINDRIYP
     YAAISYEEWN DPPAVKWGSV SNPLFLPLIP PQSQGFTAIV LTYDRVESLF RVITEVSKVP
     SLSKLLVVWN NQNKNPPEDS LWPKIRVPLK VVRTAENKLS NRFFPYDEIE TEAVLAIDDD
     IIMLTSDELQ FGYEVWREFP DRLVGYPGRL HLWDHEMNKW KYESEWTNEV SMVLTGAAFY
     HKYFNYLYTY KMPGDIKNWV DAHMNCEDIA MNFLVANVTG KAVIKVTPRK KFKCPECTAI
     DGLSLDQTHM VERSECINKF ASVFGTMPLK VVEHRADPVL YKDDFPEKLK SFPNIGSL
//
